[Effects of TIEG1 on K562 cell apoptosis and expression of BCL-2/BAX, PTEN]

Kun Yao1, Hai-Xia Zhu1, Rong Zhang1

  • 1Hematology Center of China Medical University Shengjing Hospital, Shengyang 100021, Liaoning Province, China.

Insights

This study shows TIEG1 inhibits K562 cell proliferation and induces apoptosis in a time- and dose-dependent manner. TIEG1 influences BCL-2, BAX, and PTEN expression during K562 cell apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • K562 cells are a human chronic myeloid leukemia cell line.
  • Apoptosis is programmed cell death, crucial in cancer development and treatment.
  • BCL-2, BAX, and PTEN are key regulators of apoptosis.

Purpose of the Study:

  • To investigate the effect of TIEG1 on K562 cell apoptosis.
  • To examine the impact of TIEG1 on the expression of BCL-2, BAX, and PTEN in K562 cells.

Main Methods:

  • K562 cells were treated with varying concentrations of TIEG1.
  • Cell proliferation inhibition was assessed using the MTT assay.
  • Apoptosis was detected by flow cytometry.
  • Gene expression levels of BCL-2, BAX, and PTEN were analyzed using RT-PCR.

Main Results:

  • TIEG1 demonstrated a time- and dose-dependent inhibition of K562 cell proliferation.
  • TIEG1 treatment significantly increased K562 cell apoptosis rates in a time-dependent manner.
  • TIEG1 treatment led to decreased BCL-2 expression and increased BAX and PTEN expression.

Conclusions:

  • TIEG1 effectively inhibits K562 cell proliferation and induces apoptosis.
  • The observed apoptosis in K562 cells is associated with altered expression of BCL-2, BAX, and PTEN.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
9
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K